Box score
Ascendia Pharmaceuticals, Inc.
Reported $4.1M sold in a new Form D filed July 24, 2026 (North Brunswick, New Jersey).
- Biggest raise
- $4.1M filed Jul 24, 2026
- League
- Bio & Health Other Health Care
- Based in
- North Brunswick, New Jersey
- Season rank
- #373 of 1,121 in the Bio & Health League; #3207 of 10,745 overall (2026)
- Incorporated
- 2021
- Entity
- Corporation
Form D filings since 2024 3
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-07-24 | New notice | $4.1M | $4.1M | SEC |
| 2025-06-04 | New notice | $2.5M | $2.5M | SEC |
| 2024-10-11 | New notice | $2.5M | $2.5M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1855888.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Galenus Precision Pharmacy, Inc. rookie | Bio & Health | $5.4M |
| 2 | Linnaeus Therapeutics, Inc. | Bio & Health | $4.5M |
| 3 | TETmedical, Inc. | Bio & Health | $3.5M |
| 4 | Hepion Pharmaceuticals, Inc. | Bio & Health | $3.1M |
| 5 | Corfigo, Inc. | Bio & Health | $2.4M |
| 6 | Milestone Scientific Inc. | Bio & Health | $2.1M |